Free Trial

Novozymes A/S (OTCMKTS:NVZMY) Shares Cross Below 200-Day Moving Average - Time to Sell?

Novozymes A/S logo with Basic Materials background

Key Points

  • Novozymes A/S shares fell below their 200-day moving average of $65.76, trading at $61.34, raising concerns among investors.
  • Zacks Research downgraded Novozymes A/S from a "strong-buy" to a "hold" rating, leading to an average rating of "Hold" from analysts.
  • The company recently announced a dividend payment of $0.1856 per share, reflecting a dividend yield of 88.0%, with a payout ratio of 23.42%.
  • Five stocks to consider instead of Novozymes A/S.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $65.76 and traded as low as $60.77. Novozymes A/S shares last traded at $61.34, with a volume of 22,251 shares.

Analysts Set New Price Targets

Separately, Zacks Research cut shares of Novozymes A/S from a "strong-buy" rating to a "hold" rating in a report on Monday, August 25th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold".

Get Our Latest Stock Report on NVZMY

Novozymes A/S Trading Up 0.3%

The company has a debt-to-equity ratio of 0.28, a current ratio of 1.75 and a quick ratio of 1.07. The company's fifty day moving average is $63.55 and its 200-day moving average is $65.76. The stock has a market cap of $28.73 billion, a PE ratio of 38.82, a PEG ratio of 1.20 and a beta of 0.97.

Novozymes A/S Cuts Dividend

The firm also recently announced a dividend, which was paid on Thursday, September 11th. Investors of record on Wednesday, September 3rd were issued a dividend of $0.1856 per share. This represents a dividend yield of 88.0%. The ex-dividend date of this dividend was Tuesday, September 2nd. Novozymes A/S's dividend payout ratio (DPR) is 23.42%.

About Novozymes A/S

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novozymes A/S Right Now?

Before you consider Novozymes A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.

While Novozymes A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.